You + Us

Your advantage in the fight against cancer.

The expertise of Texas Oncology and Baylor Scott & White, combined with the comprehensive cancer program at Baylor University Medical Center, offers patients like you a convenient destination for innovative oncology services like immunotherapies and clinical trials. By teaming up with your physician, we're able to give you the advanced treatment you need now so you can continue your long-term care back at home.

Request a Callback

What Makes Us Different

  • Access to many first in market immunotherapies
  • One of the largest cancer treatment centers in the United States and the only medical center in North Texas that has the capability to both manufacture novel immunotherapy cancer treatments and deliver them to patients on the same campus
  • Treatment from the first North Texas facilities to offer adult commercial use of chimeric antigen receptor (CAR) T-cell therapy, to treat patients with lymphoma, leukemia, and myeloma
  • Treatment from one of the first in the nation to offer FDA-approved tumor-infiltrating lymphocytes (TIL) cellular therapy for patients with metastatic melanoma
  • Care from a skilled team with expertise in immunotherapy research, development and clinical trials
  • Baylor University Medical Center is designated by ANCC's Magnet Recognition Program® and has a nursing staff skilled in administering immuno-oncology therapies and related care
  • Baylor Scott & White T. Boone Pickens Cancer Hospital is the only dedicated cancer hospital in North Texas
  • The American Cancer Society's Hope Lodge offers free/low-cost accommodations on the Baylor Dallas campus
  • Baylor Dallas offers the only after-hours cancer urgent care in DFW

Compassion + Expertise = The Patient Journey

The multidisciplinary teams from Baylor University Medical Center and Texas Oncology provide personalized and comprehensive treatment plans with access to all the resources on the Baylor Dallas campus. While every patient journey is different based on your specific therapy or clinical trial, our goal is to provide a seamless, holistic experience for each patient.

What might a typical journey look like?

  1. 02-DA-194566-VisionforCellularTherapyCampaign-PatientJourney-1.jpg

    Travel to Dallas, stay at free/low-cost accommodations while attending outpatient appointments and collecting your immune cells at Baylor Scott & White T. Boone Pickens Cancer Hospital or Texas Oncology.

  2. 02-DA-194566-VisionforCellularTherapyCampaign-PatientJourney-2.jpg

    Return home while your immune cells are manufactured into an immune therapy.

  3. 02-DA-194566-VisionforCellularTherapyCampaign-PatientJourney-3.jpg

    Return to Dallas for immune therapy infusion.

  4. 02-DA-194566-VisionforCellularTherapyCampaign-PatientJourney-4.jpg

    After immune therapy, return to your local oncologist for periodic follow-up and long-term care.

  • Sue

    Cancer Survivor

    Sue’s cancer journey began years before her official diagnosis. In 2012, doctors noticed a nodule on her pancreas and made the decision to watch it closely with routine scans and observations. Three years later, Sue was officially diagnosed with pancreatic cancer. She credits her medical team’s diligence for finding her cancer early. That attentiveness continued through her clinical trial treatment as her doctors kept her and husband informed every step of the way. Today Sue is cancer free and is forever grateful for her doctors, nurses and family members for supporting her throughout her entire treatment.

  • Thomas

    Cancer Survivor

    After being diagnosed with allergies by a family physician, Thomas knew something still didn’t feel right. A visit to the ER confirmed he had a lymphatic tumor. When chemotherapy and a stem cell transplant didn’t work, Dr. Koshy put Thomas on a CAR T-cell therapy treatment. Because his case was so aggressive, Thomas was grateful to finally find a treatment that was successful. He gets stronger and stronger every day and looks forward to being back on the golf course soon.

  • Tiffany

    Cancer Survivor

    When Tiffany was diagnosed with cancer, she thought life might never be the same. Then she met Dr. Reynolds and discovered she could receive advanced care close to home and her family. Knowing Tiffany had an interest in medicine, Dr. Reynolds explained every scientific detail throughout treatment. Immunotherapy not only gave Tiffany her life back, it solidified her decision to become a physician. She is forever grateful to Dr. Reynolds and her team.

Cell Therapy + Us = An Unrelenting Duo

Traditional surgery, chemotherapy and radiation are no longer the only cancer treatments available. Immunotherapy is changing the game by using your body's own immune cells to attack cancer.

The FDA-approved CAR-T cell therapies currently available are for patients with multiple myeloma, lymphoma or leukemia. Patient eligibility varies by product; however, most CAR-T cell therapies are indicated for patients who have either not responded to or relapsed after at least one other type of cancer therapy. Clinical trials are available for some cellular therapy in solid tumor cancers.

  • CAR-T Therapy After taking T cells, a type of immune cell from your blood, a synthetic receptor called a chimeric antigen receptor (CAR) is added to your T- cells in the lab, and the cells are multiplied. These new T-cells are then infused back into your body to target specific antigens on the surface of cancer cells.
  • Natural Killer (NK) Cell Therapy A natural killer (NK) cell is a type of immune cell that looks for any abnormal cells in the body and attacks them. In the lab, NK cells can be multiplied or modified and then infused into your body to help the body better attack cancer cells.
  • Tumor-Infiltrating Cells These are immune cells that go from your blood into a tumor to kill cancer cells. They can be taken from your tumor and multiplied in the lab. This larger number of cells is then infused back into your body to boost the immune system's ability to destroy cancer.
  • T Cell Receptor (TCR) Therapy Modifies your own T-cells in the lab with a receptor that can target specific cancer cells. These modified cells are multiplied and infused back into your body to attack cancer.
  • Therapeutic Vaccines When modified in the lab and delivered as a vaccine, immature dendritic cells, a type of immune cell, can help prompt the immune system to target cancer cells as invaders.
  • Bispecific Antibodies These are antibodies that bind two different targets, creating a superior therapeutic effect to monoclonal antibodies and a broader treatment for disease.

Want to find out more information about our clinical trials?

We've got you covered.

Submit the form below to learn more.

Request a Callback

If you have been diagnosed with a blood cancer or solid tumor and would like to schedule an appointment, fill out our form, and we’ll be in touch with you soon.

Thank You for Submitting The Form

A member of our care team will be in contact with you soon regarding your request.

Explore Hope Lodge

We are proud to offer patients access to the American Cancer Society's Hope Lodge, which offers free/low-cost accommodations on the Baylor Dallas campus.